These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26983524)

  • 1. Reproducibility: Team up with industry.
    Edwards A
    Nature; 2016 Mar; 531(7594):299-301. PubMed ID: 26983524
    [No Abstract]   [Full Text] [Related]  

  • 2. Massachusetts: Mass effect.
    Savage N
    Nature; 2016 Sep; 537(7618):S18-9. PubMed ID: 27580137
    [No Abstract]   [Full Text] [Related]  

  • 3. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug giants hamstrung by timid middle management.
    Firestone RA
    Nature; 2006 May; 441(7091):282. PubMed ID: 16710394
    [No Abstract]   [Full Text] [Related]  

  • 5. Industrial-strength bonds.
    Nature; 2015 Nov; 527(7577):S76-9. PubMed ID: 26560455
    [No Abstract]   [Full Text] [Related]  

  • 6. Looking outward: content as a service starts to make sense.
    Sherlock A
    Drug Discov Today; 2013 Jan; 18(1-2):1-3. PubMed ID: 23041498
    [No Abstract]   [Full Text] [Related]  

  • 7. Industry: Shared goals score reproducible results.
    Buenz E
    Nature; 2016 May; 533(7601):36. PubMed ID: 27147021
    [No Abstract]   [Full Text] [Related]  

  • 8. Sanofi takeover jeopardizes Aventis biotech deals.
    Mitchell P
    Nat Biotechnol; 2004 Jun; 22(6):639-40. PubMed ID: 15175667
    [No Abstract]   [Full Text] [Related]  

  • 9. Escaping the pincer.
    Nat Rev Drug Discov; 2009 Dec; 8(12):915. PubMed ID: 19967796
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing the health of early-stage discovery.
    Edwards M; Tramontin T; Simon D; Dhankhar A; Sheikh M
    Nat Rev Drug Discov; 2011 Mar; 10(3):171-2. PubMed ID: 21358730
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
    Laverty H; Gunn M; Goldman M
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID has shown the power of science-industry collaboration.
    Nature; 2021 Jun; 594(7863):302. PubMed ID: 34135530
    [No Abstract]   [Full Text] [Related]  

  • 13. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deal watch: Ablynx and Merck Serono collaborate on next-generation antibody products.
    Nat Rev Drug Discov; 2008 Nov; 7(11):881. PubMed ID: 18974745
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving R&D productivity.
    Smietana K; Ekstrom L; Jeffery B; Møller M
    Nat Rev Drug Discov; 2015 Jul; 14(7):455-6. PubMed ID: 26065405
    [No Abstract]   [Full Text] [Related]  

  • 16. Priorities for improving drug research, development and regulation.
    Forda SR; Bergström R; Chlebus M; Barker R; Andersen PH
    Nat Rev Drug Discov; 2013 Apr; 12(4):247-8. PubMed ID: 23535921
    [No Abstract]   [Full Text] [Related]  

  • 17. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
    Forster SP; Stegmaier J; Spycher R; Seeger S
    Drug Discov Today; 2014 Mar; 19(3):348-55. PubMed ID: 24291787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of quality, capacity, and productivity at Merck.
    Nathan J; Venkataraman R
    Hosp Mater Manage Q; 1999 Feb; 20(3):64-9. PubMed ID: 10345635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Driving external chemistry optimization via operations management principles.
    Bi FC; Frost HN; Ling X; Perry DA; Sakata SK; Bailey S; Fobian YM; Sloan L; Wood A
    Drug Discov Today; 2014 Mar; 19(3):289-94. PubMed ID: 23973340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garry Neil. Interview by Asher Mullard.
    Neil G
    Nat Rev Drug Discov; 2012 Nov; 11(11):826. PubMed ID: 23123934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.